This site is intended for healthcare professionals
banner image
CDK4/6 inhibitors in breast cancer

Participant's evaluation form

Read time: 5 mins
Last updated:21st Jul 2022
Published:21st Jul 2022

Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Eli Lilly, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.